Craig Martin CSO, Co-founder, President
Inna Shcherbakova, CEO, Co-founder
Melissa Moore, Co-founder, Board Chair
Next Generation Manufacturing for RNA for Rapidly Emerging Therapeutics
Waterfall Scientific is developing new technologies and approaches for RNA synthesis, providing unprecedented purity at low production costs.
Current RNA batch manufacturing produces problematic dsRNA (double stranded RNA) that triggers inflammation, which is holding back a vast number of RNA therapies.
Waterfall Scientific brings a flow manufacturing approach to RNA synthesis with dramatically increased yield and purity per template DNA in order to eliminate immunogenicity before purification.
